Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2005
10/19/2005CN1682787A Ruankang good for breast
10/19/2005CN1682786A Adhesive plaster
10/19/2005CN1682785A Liumotang preparation
10/19/2005CN1682784A Traumatic injury safflower medicinal preparation
10/19/2005CN1682781A Eggplant root extract and its preparing method and use
10/19/2005CN1682779A Powder for treating hepatitis B and liver cirrhosis
10/19/2005CN1682777A Capsule for treating gastropathy
10/19/2005CN1682775A Eucommia bark tablet and its preparing method
10/19/2005CN1682770A Process for preparing bee glue water solution and use
10/19/2005CN1682768A Naoxinshu solid preparation good for brain and heart
10/19/2005CN1682767A Pearl powder soft capsule
10/19/2005CN1682760A Multiple micro element for injection and preparing method
10/19/2005CN1682758A Aluminium sulfate for injection and aluminium sulfate injection for treating bladder tumor
10/19/2005CN1682756A Supplementing method for exogenous nitric oxide
10/19/2005CN1682755A Material for treating inflammation and pain
10/19/2005CN1682754A Ginseng-gaboderma lucidum tranquilizing dripping pill and its preparing method
10/19/2005CN1682752A Process for preparing lentinan drip liquid
10/19/2005CN1682751A Agaric polysaccharide freeze-dried powder injection and its preparing method
10/19/2005CN1682749A Flavone composition for sobering and liver protection and its use
10/19/2005CN1682745A Nano capsule containing glycyrrhizic acid medicine and its preparing method
10/19/2005CN1682744A Method for preparing asiaticoside cataplasm
10/19/2005CN1682743A Pharmaceutical formulations
10/19/2005CN1682741A Anti-cancer medicine 23-hydroxy betulic acid fat emulsion and its preparing method
10/19/2005CN1682739A Cefadroxil dry suspension and preparing method
10/19/2005CN1682738A Spray containing molsidomine
10/19/2005CN1682737A Compound dimethylbiguanide/glipizide control release tablet and preparing method
10/19/2005CN1682736A Gatifloxacin lactate injection and its preparing method
10/19/2005CN1682735A Soft capsule containing flunarizine
10/19/2005CN1682734A Oral disintegration tablet of dihydroergotoxine and its derivatives and its preparing process
10/19/2005CN1682730A Cepharanthine slow releasing preparation
10/19/2005CN1682729A Fibrauretin dripping pill and its preparing method
10/19/2005CN1682728A Stable palonosetron injection
10/19/2005CN1682727A Freeze-dried preparation containing balofloxacin and its use
10/19/2005CN1682726A Inclusion containing raltitrexed and preparation
10/19/2005CN1682725A Inclusion containing raltitrexed and its powder injection
10/19/2005CN1682723A Scopolamine hydrobromide dry powder inhalant for nose and preparing method
10/19/2005CN1682721A Tropisetron hydrochloride oral disintegration tablet preparation and its preparing method
10/19/2005CN1682720A Berberine hydrochloride dispensing tablet and its preparing method
10/19/2005CN1682719A Enteric soluble coating slow releasing tablet containing huperzine A and preparing method
10/19/2005CN1682718A Telmisartan dispersing tablet and its preparing method
10/19/2005CN1682716A External plaster for treating skin tinea and skin rhagas
10/19/2005CN1682713A Use of ampelopsin in preparing medicine for treating diseases related with aldose reductase
10/19/2005CN1682710A Water soluble soybean aglycone medicinal composition and its preparing method
10/19/2005CN1682709A Furosemide oral disintegration tablet and its preparing method
10/19/2005CN1682708A External use analgesic cream for transfusion
10/19/2005CN1682707A Pharmaceutical composition comprising fenofibrate and process for its preparation
10/19/2005CN1682706A Stable oil-in-water emulsion of propyl gallate for vein and its preparing method
10/19/2005CN1682705A Skin plaster containing aceclofenac
10/19/2005CN1682704A Levodopa nano preparation and its preparing method
10/19/2005CN1682703A Sterilizing gel
10/19/2005CN1682701A Self microemulsifying preparation of curcumin and its preparing process
10/19/2005CN1682699A Colon soluble and intestine soluble hollow hard capsule and producing process
10/19/2005CN1682698A Method for preventing content adhesion in soft capsule with high solid content
10/19/2005CN1682697A Effervescent lozenge and its preparing process
10/19/2005CN1682696A Timing slow-releasing micrpill and its preparation
10/19/2005CN1682695A Method for promoting liposome lymph absorption and reducing normal lymph node accumulation
10/19/2005CN1682694A Wet micro particle grinding method
10/19/2005CN1682693A In site gel medicine transfer system for hardening treating angioma and vascular deformity
10/19/2005CN1682692A Molecular gel transdermal medicine preparation and its preparing method
10/19/2005CN1682691A Process for preparing medicinal syrup
10/19/2005CN1223589C Potassium sodium dehydroandroandrographolide succinates and their preparations
10/19/2005CN1223378C Cyclodextrin containing glycopeptides antibiotic pharmaceutical compositions
10/19/2005CN1223373C Sore throat relieving preparation
10/19/2005CN1223372C Capsule for treating gastritis and gastric ulcer its preparing method
10/19/2005CN1223367C Ointment for treating brandy nose and face acne
10/19/2005CN1223364C Infusion preparation of gingko leaves and its preparing method
10/19/2005CN1223360C Chinese medicine for treating qi obstruction in chest
10/19/2005CN1223355C Dermatitis treating ointment and its prepn
10/19/2005CN1223352C Liposome ointment containing heparin kind medicine and its preparation method
10/19/2005CN1223347C Aqueous cilostazol preparation for injection
10/19/2005CN1223346C Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents
10/19/2005CN1223342C Sucrose ester-C20-28 alcohol preparation
10/19/2005CN1223341C Spheroids, preparation method and pharmaceutical compositions
10/19/2005CN1223340C Electrospun pharmaceutical compositions
10/19/2005CN1223339C Implanted degradable high molecular material medicine control-release carrier and its preparing process
10/19/2005CN1223338C Cetirizine hydrochloride gel
10/18/2005US6956144 Mixture with flow control agents; antiulcer agents
10/18/2005US6956048 Pharmaceutical emulsions for retroviral protease inhibitors
10/18/2005US6956043 Pharmaceutical compositions comprising 33-epi-chloro-33-desoxy-ascomycin solid dispersions
10/18/2005US6956030 Treating disease of the airway passages and lungs such as asthma and allergic rhinitis by administering intranasally or oral inhalation; low bioavailability and low systemic side-effects; aerosols
10/18/2005US6956029 Solid formulation of glucosamine sulphate
10/18/2005US6956021 Stable spray-dried protein formulations
10/18/2005US6955903 Enzymatic polypeptide for use in treating lactose intolerance
10/18/2005US6955888 Methods of screening agents, conjugates or conjugate moieties for transport by a PEPT2 transporter
10/18/2005US6955842 Sealing medium for composite packaging materials
10/18/2005US6955827 Method of controlling release of antimicrobial agents in chewing gum
10/18/2005US6955825 Compositions and methods for high sorption of skin materials and delivery of sulfur
10/18/2005US6955824 Inhalation composition containing lactose pellets
10/18/2005US6955823 forming dispersion of oil in water in presence of surfactant, heating above phase inversion temperature to form bicontinuous phase composition, cooling to below phase inversion temperature to form emulsion of oil drops in water, encapsulating
10/18/2005US6955822 Lactone bearing absorbable polymers
10/18/2005US6955821 Sustained release formulations of guaifenesin and additional drug ingredients
10/18/2005US6955819 extra bolus of drug can be delivered into patient's body by heating the skin and sub-skin tissues under a transdermal drug delivery system that has been on the skin for sufficient time to establish a depot site of the drug
10/18/2005US6955818 for control of an external parasite on an animal of agricultural worth comprising 0.1 to 40% by weight of at least one spinosyn, and a non-irritant topically acceptable carrier, for example, tripropylene glycol methyl ether and benzyl alcohol
10/18/2005US6955815 Combinations for the treatment of inflammatory disorders
10/18/2005CA2372802C Emulsion-based processes for making microparticles
10/18/2005CA2340054C Oral administration form for pyridin-2-ylmethylsulfinyl-1h-benzimidazoles
10/18/2005CA2282082C Microgranules containing cisplatin
10/18/2005CA2279898C Elastomer treatment process to decrease peroxide levels
10/18/2005CA2264588C Solid foamed active substance preparations
10/18/2005CA2262595C Easy to swallow oral medicament composition
1 ... 1736 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 1748 1749 1750 1751 1752 1753 1754 1755 1756 ... 2991